Brain metastases in lung adenocarcinoma: impact of EGFR mutation status on incidence and survival von Stanic, Karmen, Zwitter, Matjaz, Turnsek Hitij, Nina, Kern, Izidor, Sadikov, Aleksander, Cufer, Tanja

Volltext

Immunohistochemistry for EGFR Mutation Detection in Non–Small-Cell Lung Cancer von Hitij, Nina Turnšek, Kern, Izidor, Sadikov, Aleksander, Knez, Lea, Stanič, Karmen, Zwitter, Matjaž, Cufer, Tanja

Volltext

MA08.09 Monitoring Plasma EGFR Mutations during First Line Treatment with EGFR TKIs in NSCLC Patients von Mohorcic, Katja, Kern, Izidor, Janzic, Urska, Hitij, Nina Turnsek, Rot, Mitja, Cufer, Tanja

Volltext

P16. Is type of EGFR mutation predictive for incidence and survival in lung adenocarcinoma patients with brain metastases? von Stanic, Karmen, Hitij, Nina Turnsek

Volltext

O12. Survival of patients with advanced EGFR-mutated NSCLC treated with EGFR TKIS in routine clinical practice von Hitij, Nina Turnsek, Sadikov, Aleksander, Knez, Lea, Mohorcic, Katja, Jakelj, Andraz, Cufer, Tanja

Volltext

P8. Efficacy of first-line pemetrexed/platinum chemotherapy in the treatment of advanced NSCLC in routine clinical practice von Mohorcic, Katja, Hitij, Nina Turnsek, Knez, Lea, Sadikov, Aleksander, Jakelj, Andraz, Cufer, Tanja

Volltext

P19. Overall survival in advanced lung cancer patients proposed to receive initial chemotherapy according to actual chemotherapy delivery von Knez, Lea, Sadikov, Aleksander, Jakelj, Andraž, Mohorcic, Katja, Hitij, Nina Turnšek, Cufer, Tanja

Volltext

Presejanje na okužbo z virusom hepatitisa B in preprečevanje reaktivacije hepatitisa B von Tanja Čufer, Tanja Južnič Šetina, Boštjan Šeruga, Nina Turnšek Hitij, Brigita Gregorič

Volltext